China Pharma Inc. (CPHI)
AMEX: CPHI
· Real-Time Price · USD
1.48
0.02 (1.37%)
At close: Aug 15, 2025, 9:41 AM
China Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1,136.3B | 4.53M | 5.54M | 6.25M | 6.42M | 7.01M | 7.78M | 7.95M | 8.46M | 8.1M | 8.07M | 8.09M | 8.89M | 9.64M | 9.68M | 10.11M | 11.46M |
Cost of Revenue | 1,272.4B | 6.62M | 7.62M | 8.03M | 7.23M | 7.35M | 7.94M | 8.01M | 8.61M | 8.6M | 8.31M | 8.48M | 8.98M | 9.29M | 9.07M | 9.15M | 9.43M |
Gross Profit | -136.06B | -2.09M | -2.07M | -1.78M | -811.29K | -343.34K | -159.25K | -63.81K | -146.53K | -493.92K | -234.66K | -393.3K | -92.92K | 349.27K | 608.81K | 952.4K | 2.03M |
Operating Income | -758.62B | -4.59M | -4.58M | -4.21M | -3.27M | -1.4M | -1.4M | -1.37M | -1.69M | -3.56M | -1.61M | -1.68M | -1.65M | -1.44M | -3.31M | -3.5M | -2.68M |
Interest Income | 1.07B | 6.64K | 7.84K | 8.56K | 7.97K | 6.6K | 5.08K | 4.75K | 5.05K | 10.76K | 11.16K | 9.95K | 9.28K | 3.04K | 2.04K | 5.06K | 5.7K |
Pretax Income | -785.58B | -4.74M | -4.74M | -4.4M | -3.56M | -3.08M | -3.11M | -3.12M | -3.42M | -3.97M | -3.69M | -3.73M | -3.66M | -3.4M | -3.63M | -3.81M | -2.97M |
Net Income | -785.58B | -4.74M | -4.74M | -4.4M | -3.56M | -4.6M | -4.71M | -4.72M | -6.6M | -7.3M | -9.02M | -9.06M | -7.41M | -5.48M | -3.63M | -3.81M | -2.97M |
Selling & General & Admin | 594.29B | 2.31M | 2.18M | 2.15M | 2.23M | 2.19M | 2.48M | 2.56M | 2.82M | 2.94M | 2.91M | 2.81M | 3.04M | 3.14M | 3.32M | 3.83M | 4.11M |
Research & Development | 29.59B | 283.94K | 430.95K | 389.11K | 248.52K | 240.08K | 120.53K | 163.5K | 154.82K | 185.86K | 211.91K | 144.53K | 182.93K | 318.96K | 526.39K | 542.64K | 519.23K |
Other Expenses | -95.5K | -97.56K | -98.51K | -98.51K | -2.07K | 10.04K | 20.17K | 20.17K | 24.53K | 20.02K | 9.88K | 8.37B | 8.37B | 8.37B | 123.56B | 132.57B | 132.57B |
Operating Expenses | 623.88B | 2.36M | 2.51M | 2.44M | 2.47M | 2.43M | 2.61M | 2.74M | 2.99M | 3.15M | 976.46K | -114.29K | -1.49M | -3.21M | -3.92M | -4.46M | -4.71M |
Interest Expense | -28.03B | 154.14K | 174.66K | 206.79K | 296.31K | 333.6K | 379.52K | 417.26K | 389.64K | 434.62K | 671.88K | 632.81K | 595.16K | 542K | 316.5K | 312.67K | 303.42K |
Selling & Marketing Expenses | 87.11B | 528.82K | 613.8K | 685.72K | 744.08K | 780.33K | 885.17K | 938.02K | 1.03M | 1.07M | 1.24M | 1.12M | 1.3M | 1.5M | 1.47M | 1.99M | 2.27M |
Cost & Expenses | 1,896.2B | 9.12M | 10.12M | 10.47M | 9.71M | 8.63M | 6.96M | 7.15M | 6.89M | 6.72M | 6.69M | 5.77M | 6M | 6.08M | 5.15M | 4.7M | 4.72M |
Income Tax Expense | n/a | n/a | 3.00 | 3.00 | 3.00 | 1.52M | 1.6M | 1.6M | 3.18M | 3.33M | 5.33M | 5.33M | 3.75M | 2.09M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 32.62M | 17.46M | 17.31M | 16.12M | 13.13M | 10.63M | 10.57M | 9.92M | 8.08M | 6.44M | 4.61M | 4.85M | 4.74M | 4.78M | 4.61M | 4.61M | 4.61M |
Shares Outstanding (Diluted) | 32.62M | 17.46M | 17.31M | 16.12M | 13.13M | 10.63M | 10.57M | 9.92M | 8.08M | 6.44M | 4.61M | 4.94M | 4.74M | 4.78M | 4.61M | 4.61M | 4.61M |
EPS (Basic) | -24.08K | -0.3 | -0.35 | -0.36 | -0.33 | -0.5 | -0.59 | -1.31 | -1.76 | -2.08 | -2.51 | -1.9 | -1.57 | -1.17 | -0.81 | -0.86 | -0.68 |
EPS (Diluted) | -24.08K | -0.3 | -0.35 | -0.36 | -0.33 | -0.5 | -0.59 | -1.31 | -1.75 | -2.07 | -2.5 | -1.89 | -1.57 | -1.17 | -0.81 | -0.86 | -0.68 |
EBITDA | -758.62B | -1.96M | -1.7M | -1.34M | -453.56K | 9.73K | -32.73K | -26.92K | -362.44K | -837.29K | -245.27K | -8.12K | 34.71K | 230.34K | -233.08K | -723.3K | 53.95K |
EBIT | -3.67M | -4.58M | -4.57M | -4.2M | -3.26M | -2.75M | -2.73M | -2.71M | -3.03M | -3.54M | -3.02M | -3.09M | -3.07M | -2.86M | -3.31M | -3.5M | -2.67M |
Depreciation & Amortization | 1.89M | 2.62M | 2.87M | 2.85M | 2.81M | 2.75M | 2.7M | 2.68M | 2.67M | 2.7M | 2.77M | 3.08M | 3.1M | 3.09M | 3.08M | 2.78M | 2.72M |